Lymphangioleiomyomatosis

Also known as: Lymphangioleiomyomatosis (LAM) / Lymphangiomyomatosis / Lymphangiomyomatosis (morphologic abnormality)

DrugDrug NameDrug Description
DB00877SirolimusAn mTOR inhibitor immunosuppressant used to prevent organ transplant rejections, treat lymphangioleiomyomatosis, and treat adults with perivascular epithelioid cell tumors.
DrugDrug NamePhaseStatusCount
DB09277Choline C 110Not Yet Recruiting1
DB00112Bevacizumab1Active Not Recruiting1
DB00002Cetuximab1Active Not Recruiting1
DB01611Hydroxychloroquine1Completed1
DB00130L-Glutamine1Completed1
DB14123Menthol1Active Not Recruiting1
DB00877Sirolimus1Active Not Recruiting1
DB00877Sirolimus1Completed1
DB06287Temsirolimus1Active Not Recruiting1
DB00313Valproic acid1Active Not Recruiting1
DB11114Eucalyptus oil1 / 2Recruiting1
DB01590Everolimus1 / 2Completed2
DB00619Imatinib1 / 2Completed1
DB10984Peppermint1 / 2Recruiting1
DB01001Salbutamol1 / 2Recruiting1
DB00641Simvastatin1 / 2Completed1
DB00877Sirolimus1 / 2Completed1
DB11195Xylitol1 / 2Recruiting1
DB00482Celecoxib2Completed1
DB01590Everolimus2Completed1
DB01006Letrozole2Completed1
DB00455Loratadine2Recruiting1
DB09079Nintedanib2Completed1
DB00104Octreotide2Completed1
DB02709Resveratrol2Completed1
DB00877Sirolimus2Completed3
DB00877Sirolimus2Recruiting1
DB00877Sirolimus2Unknown Status1
DB01590Everolimus3Completed1
DB00877Sirolimus3Completed1
DB00877Sirolimus3Recruiting1
DB00254Doxycycline4Completed1
DB01590EverolimusNot AvailableRecruiting1
DB00877SirolimusNot AvailableRecruiting1